Drug intelligence / Profile preview

penicacid S

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Penicacid S is a novel mycophenolic acid derivative isolated from the marine-derived fungus *Penicillium senticosum* RCDB005, which was collected from sediment samples in the South China Sea. It is one of several penicacids (O-W) identified as secondary metabolites with potential antineoplastic properties. In preclinical in vitro studies, penicacid S demonstrated potent anti-proliferative activity against human cancer cell lines, specifically showing significant inhibition of the MOLM-13 acute myeloid leukemia (AML) cell line with IC50 values ranging from 0.13 to 1.13 μM. As a derivative of mycophenolic acid, its mechanism of action is likely associated with the inhibition of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in the de novo biosynthesis of guanosine nucleotides. This inhibition leads to the depletion of intracellular guanine nucleotide pools, thereby arresting DNA synthesis and cell proliferation in malignant cells.

02

Targets

IMPDH (Inosine-5'-monophosphate dehydrogenase 1)

Beyond the preview

Go deeper on penicacid S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on penicacid S.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call